The appendix in intestinal immunity and inflammatory bowel disease
The appendix in intestinal immunity and inflammatory bowel disease
批准号:
nhmrc : 455466
负责人:
Prof Andrew Lloyd
金额:
$31.02万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2007
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2007-01-01 至 2009-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Inflammatory bowel diseases (IBD) consist of two entities: ulcerative colitis and Crohn's disease. IBD causes relapsing and remitting gut inflammation in relatively young populations of patients. Our understanding of causes of IBD is poor, but the diseases involve an interaction between the intestinal immune system, genetic predisposition and bacteria in the gut. One unexplained observation, made by a number of groups, is that removal of the appendix, especially if performed when young, protects against the later development of ulcerative colitis and probably Crohn s disease. If IBD does develop following earlier appendicectomy, it tends to be less severe. In this project, we plan to examine the immune features of the appendix, in human and mouse. The appendix is a major source of immune cells in the intestine but the nature of these cells and their functions are poorly understood. The aims of the project will explore the nature of immune cells, known as T lymphocytes, isolated from human and mouse appendices. Changes with age will be examined, to explain the age-related nature of the appendicectomy-IBD link. Anti- and pro-inflammatory characteristics of the cells will be studied, the migration pathways of these cells from appendix to other parts of the intestine will be clarified, and the therapeutic potential of these T cells in a mouse model of IBD will be elucidated. In addition, this will be the first study to develop and analyse a mouse model of appendicitis, which is very poorly understood. These studies will make important observations relevant not only to IBD, but to the immune function of the intestine, with implications for our fundamental understanding of the way we are protected from our hostile environment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving the health of people with problematic drug use: hepatitis C and drug dependence
-
批准号:nhmrc : 1150078
-
项目类别:Program Grants
-
资助金额:$604.13万
-
财政年份:2019
-
负责人:Prof Andrew Lloyd
-
依托单位:
Improving the health of people with problematic drug use: hepatitis C and drug dependence
-
批准号:nhmrc : GNT1150078
-
项目类别:Programs
-
资助金额:$906.01万
-
财政年份:2019
-
负责人:Prof Andrew Lloyd
-
依托单位:
Determinants of the outcomes from infectious diseases
-
批准号:nhmrc : 1137587
-
项目类别:Practitioner Fellowships
-
资助金额:$39.03万
-
财政年份:2018
-
负责人:Prof Andrew Lloyd
-
依托单位:
Determinants of the outcomes from infectious diseases
-
批准号:nhmrc : GNT1043067
-
项目类别:Practitioner Fellowships
-
资助金额:$35.52万
-
财政年份:2013
-
负责人:Prof Andrew Lloyd
-
依托单位:
Determinants of the outcomes from infectious diseases
-
批准号:nhmrc : 1043067
-
项目类别:Practitioner Fellowships
-
资助金额:$37.36万
-
财政年份:2013
-
负责人:Prof Andrew Lloyd
-
依托单位:
Practitioner Fellowship
-
批准号:nhmrc : 510246
-
项目类别:NHMRC Research Fellowships
-
资助金额:$34.27万
-
财政年份:2008
-
负责人:Prof Andrew Lloyd
-
依托单位:
Immune regulation, cellular trafficking and chemokine receptors in intestinal inflammation
-
批准号:nhmrc : 222752
-
项目类别:NHMRC Project Grants
-
资助金额:$13.65万
-
财政年份:2003
-
负责人:Prof Andrew Lloyd
-
依托单位:
Development of SELEX technology (Systematic Evolution of Ligands by EXponential enrichment)
-
批准号:LP0210513
-
项目类别:Linkage Projects
-
资助金额:$10.19万
-
财政年份:2002
-
负责人:Prof Andrew Lloyd
-
依托单位:
Chemokine and chemokine receptor regulation of T lymphocyte traffic to lymph nodes
-
批准号:nhmrc : 113906
-
项目类别:NHMRC Project Grants
-
资助金额:$13.05万
-
财政年份:2000
-
负责人:Prof Andrew Lloyd
-
依托单位:
Modes of transmission, natural history and determinants of viral clearance in primary hepatitis C infection
-
批准号:nhmrc : 990657
-
项目类别:NHMRC Strategic Awards
-
资助金额:$25.26万
-
财政年份:1999
-
负责人:Prof Andrew Lloyd
-
依托单位:
国内基金
海外基金
登录
查看更多内容
西方饮食通过“肠道菌群-Rspo1”轴促进肥胖与肠道吸收的机制研究
-
批准号:82370845
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:洪洁
-
依托单位:
新生儿坏死性小肠结肠炎中去泛素化酶USP15调控ILC3分化损伤肠道粘膜屏障的致病机制研究
-
批准号:82371711
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:吕志宝
-
依托单位:
“肠—肝轴”PPARα/CYP8B1胆汁酸合成信号通路在减重手术改善糖脂代谢中的作用与机制
-
批准号:82370902
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:田景琰
-
依托单位:
短链脂肪酸上调小肠上皮紧密连接屏障功能的机制
-
批准号:31040041
-
项目类别:专项基金项目
-
资助金额:10.0万元
-
批准年份:2010
-
负责人:王鹏远
-
依托单位: